<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39200025</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Identifying Cell-Penetrating Peptides for Effectively Delivering Antimicrobial Molecules into <i>Streptococcus suis</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">725</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13080725</ELocationID><Abstract><AbstractText>Cell-penetrating peptides (CPPs) are promising carriers to effectively transport antisense oligonucleotides (ASOs), including peptide nucleic acids (PNAs), into bacterial cells to combat multidrug-resistant bacterial infections, demonstrating significant therapeutic potential. <i>Streptococcus suis</i>, a Gram-positive bacterium, is a major bacterial pathogen in pigs and an emerging zoonotic pathogen. In this study, through the combination of super-resolution structured illumination microscopy (SR-SIM), flow cytometry analysis, and toxicity analysis assays, we investigated the suitability of four CPPs for delivering PNAs into <i>S. suis</i> cells: HIV-1 TAT efficiently penetrated <i>S. suis</i> cells with low toxicity against <i>S. suis</i>; (RXR)<sub>4</sub>XB had high penetration efficiency with inherent toxicity against <i>S. suis</i>; (KFF)<sub>3</sub>K showed lower penetration efficiency than HIV-1 TAT and (RXR)<sub>4</sub>XB; K8 failed to penetrate <i>S. suis</i> cells. HIV-1 TAT-conjugated PNA specific for the essential gyrase A subunit gene (TAT-anti-<i>gyrA</i> PNA) effectively inhibited the growth of <i>S. suis</i>. TAT-anti-<i>gyrA</i> PNA exhibited a significant bactericidal effect on serotypes 2, 4, 5, 7, and 9 strains of <i>S. suis</i>, which are known to cause human infections. Our study demonstrates the potential of CPP-ASO conjugates as new antimicrobial compounds for combating <i>S. suis</i> infections. Furthermore, our findings demonstrate that applying SR-SIM and flow cytometry analysis provides a convenient, intuitive, and cost-effective approach to identifying suitable CPPs for delivering cargo molecules into bacterial cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jinlu</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0003-4342-4639</Identifier><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WOAH Reference Lab for Swine Streptococcosis, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Zijing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WOAH Reference Lab for Swine Streptococcosis, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Huochun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WOAH Reference Lab for Swine Streptococcosis, Nanjing 210014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zongfu</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-6048-6829</Identifier><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Lab of Animal Bacteriology, Ministry of Agriculture, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WOAH Reference Lab for Swine Streptococcosis, Nanjing 210014, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangdong Provincial Key Laboratory of Research on the Technology of Pig-Breeding and Pig-Disease Prevention, Guangzhou 511400, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021YFD1800402</GrantID><Agency>National Key Research and Development Program of China</Agency><Country /></Grant><Grant><GrantID>R2103</GrantID><Agency>Open Project Program of Jiangsu Key Laboratory of Zoonosis</Agency><Country /></Grant><Grant><GrantID>2021ZW001</GrantID><Agency>Open Project Program of Engineering Research Center for the Prevention and Control of Animal Original Zoonosis, Fujian Province University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Streptococcus suis</Keyword><Keyword MajorTopicYN="N">antisense oligonucleotides</Keyword><Keyword MajorTopicYN="N">cell-penetrating peptides</Keyword><Keyword MajorTopicYN="N">peptide nucleic acids</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39200025</ArticleId><ArticleId IdType="pmc">PMC11350675</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13080725</ArticleId><ArticleId IdType="pii">antibiotics13080725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gori A., Lodigiani G., Colombarolli S.G., Bergamaschi G., Vitali A. Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and Applications. ChemMedChem. 2023;18:e202300236. doi: 10.1002/cmdc.202300236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202300236</ArticleId><ArticleId IdType="pubmed">37389978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorko M., Langel U. Cell-Penetrating Peptides. Methods Mol. Biol. 2022;2383:3–32. doi: 10.1007/978-1-0716-1752-6_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1752-6_1</ArticleId><ArticleId IdType="pubmed">34766279</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidotti G., Brambilla L., Rossi D. Cell-Penetrating Peptides: From Basic Research to Clinics. Trends Pharmacol. Sci. 2017;38:406–424. doi: 10.1016/j.tips.2017.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2017.01.003</ArticleId><ArticleId IdType="pubmed">28209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotadiya D.D., Patel P., Patel H.D. Cell-Penetrating Peptides: A Powerful Tool for Targeted Drug Delivery. Curr. Drug Deliv. 2024;21:368–388. doi: 10.2174/1567201820666230407092924.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567201820666230407092924</ArticleId><ArticleId IdType="pubmed">37026498</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zhang Y., Zhang C., Yu H., Ma Y., Li Z., Shi N. Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules. Pharmaceutics. 2023;15:2093. doi: 10.3390/pharmaceutics15082093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15082093</ArticleId><ArticleId IdType="pmc">PMC10459450</ArticleId><ArticleId IdType="pubmed">37631307</ArticleId></ArticleIdList></Reference><Reference><Citation>Tietz O., Cortezon-Tamarit F., Chalk R., Able S., Vallis K.A. Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells. Nat. Chem. 2022;14:284–293. doi: 10.1038/s41557-021-00866-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-021-00866-0</ArticleId><ArticleId IdType="pubmed">35145246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter M., Strieker M., Kleist C., Wischnjow A., Daniel V., Altmann A., Haberkorn U., Mier W. Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery. J. Control. Release. 2020;322:200–208. doi: 10.1016/j.jconrel.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2020.03.005</ArticleId><ArticleId IdType="pubmed">32184098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pifer R., Greenberg D.E. Antisense antibacterial compounds. Transl. Res. 2020;223:89–106. doi: 10.1016/j.trsl.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.06.001</ArticleId><ArticleId IdType="pubmed">32522669</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkowsky G., Abt C., Pohner I., Bieda A., Hammerschmidt S., Jacob A., Kreikemeyer B., Patenge N. Antimicrobial Activity of Peptide-Coupled Antisense Peptide Nucleic Acids in Streptococcus pneumoniae. Microbiol. Spectr. 2022;10:e00497-22. doi: 10.1128/spectrum.00497-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00497-22</ArticleId><ArticleId IdType="pmc">PMC9784828</ArticleId><ArticleId IdType="pubmed">36321914</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustafa D.A., Wu A.W., Zamora D., Daly S.M., Sturge C.R., Pybus C., Geller B.L., Goldberg J.B., Greenberg D.E. Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Retain Activity against Multidrug-Resistant Pseudomonas aeruginosa In Vitro and In Vivo. mBio. 2021;12:e02411-20. doi: 10.1128/mBio.02411-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02411-20</ArticleId><ArticleId IdType="pmc">PMC7844538</ArticleId><ArticleId IdType="pubmed">33436433</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller B.L., Marshall-Batty K., Schnell F.J., McKnight M.M., Iversen P.L., Greenberg D.E. Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo. J. Infect. Dis. 2013;208:1553–1560. doi: 10.1093/infdis/jit460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jit460</ArticleId><ArticleId IdType="pmc">PMC3805245</ArticleId><ArticleId IdType="pubmed">24130069</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel J. An RNA biology perspective on species-specific programmable RNA antibiotics. Mol. Microbiol. 2020;113:550–559. doi: 10.1111/mmi.14476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.14476</ArticleId><ArticleId IdType="pubmed">32185839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sully E.K., Geller B.L. Antisense antimicrobial therapeutics. Curr. Opin. Microbiol. 2016;33:47–55. doi: 10.1016/j.mib.2016.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2016.05.017</ArticleId><ArticleId IdType="pmc">PMC5069135</ArticleId><ArticleId IdType="pubmed">27375107</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Fateh M., Chatterjee A., Zhao X. A systematic review of peptide nucleic acids (PNAs) with antibacterial activities: Efficacy, potential and challenges. Int. J. Antimicrob. Agents. 2024;63:107083. doi: 10.1016/j.ijantimicag.2024.107083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2024.107083</ArticleId><ArticleId IdType="pubmed">38185398</ArticleId></ArticleIdList></Reference><Reference><Citation>Eller K.A., Aunins T.R., Courtney C.M., Campos J.K., Otoupal P.B., Erickson K.E., Madinger N.E., Chatterjee A. Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria. Commun. Biol. 2021;4:331. doi: 10.1038/s42003-021-01856-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01856-1</ArticleId><ArticleId IdType="pmc">PMC7955031</ArticleId><ArticleId IdType="pubmed">33712689</ArticleId></ArticleIdList></Reference><Reference><Citation>Good L., Nielsen P.E. Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. Biotechnol. 1998;16:355–358. doi: 10.1038/nbt0498-355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0498-355</ArticleId><ArticleId IdType="pubmed">9555726</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller B.L., Li L., Martinez F., Sully E., Sturge C.R., Daly S.M., Pybus C., Greenberg D.E. Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae. J. Antimicrob. Chemother. 2018;73:1611–1619. doi: 10.1093/jac/dky058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dky058</ArticleId><ArticleId IdType="pmc">PMC6251509</ArticleId><ArticleId IdType="pubmed">29506074</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkowsky G., Lemster A.L., Pappesch R., Jacob A., Kruger S., Schroder A., Kreikemeyer B., Patenge N. Influence of Different Cell-Penetrating Peptides on the Antimicrobial Efficiency of PNAs in Streptococcus pyogenes. Mol. Ther. Nucleic Acids. 2019;18:444–454. doi: 10.1016/j.omtn.2019.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.09.010</ArticleId><ArticleId IdType="pmc">PMC6831891</ArticleId><ArticleId IdType="pubmed">31655262</ArticleId></ArticleIdList></Reference><Reference><Citation>Patenge N., Pappesch R., Krawack F., Walda C., Mraheil M.A., Jacob A., Hain T., Kreikemeyer B. Inhibition of Growth and Gene Expression by PNA-peptide Conjugates in Streptococcus pyogenes. Mol. Ther. Nucleic Acids. 2013;2:e132. doi: 10.1038/mtna.2013.62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mtna.2013.62</ArticleId><ArticleId IdType="pmc">PMC3889189</ArticleId><ArticleId IdType="pubmed">24193033</ArticleId></ArticleIdList></Reference><Reference><Citation>Popella L., Jung J., Popova K., Ethurica-Mitic S., Barquist L., Vogel J. Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics. Nucleic Acids Res. 2021;49:4705–4724. doi: 10.1093/nar/gkab242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab242</ArticleId><ArticleId IdType="pmc">PMC8096218</ArticleId><ArticleId IdType="pubmed">33849070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy S., Sahu S.K. FtsZ inhibitors as a new genera of antibacterial agents. Bioorg. Chem. 2019;91:103169. doi: 10.1016/j.bioorg.2019.103169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioorg.2019.103169</ArticleId><ArticleId IdType="pubmed">31398602</ArticleId></ArticleIdList></Reference><Reference><Citation>Abushahba M.F., Mohammad H., Thangamani S., Hussein A.A., Seleem M.N. Impact of different cell penetrating peptides on the efficacy of antisense therapeutics for targeting intracellular pathogens. Sci. Rep. 2016;6:20832. doi: 10.1038/srep20832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20832</ArticleId><ArticleId IdType="pmc">PMC4748415</ArticleId><ArticleId IdType="pubmed">26860980</ArticleId></ArticleIdList></Reference><Reference><Citation>Popella L., Jung J., Do P.T., Hayward R.J., Barquist L., Vogel J. Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli. Nucleic Acids Res. 2022;50:6435–6452. doi: 10.1093/nar/gkac362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac362</ArticleId><ArticleId IdType="pmc">PMC9226493</ArticleId><ArticleId IdType="pubmed">35687096</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue G., Toyohara D., Mori T., Muraoka T. Critical Side Chain Effects of Cell-Penetrating Peptides for Transporting Oligo Peptide Nucleic Acids in Bacteria. ACS Appl. Bio Mater. 2021;4:3462–3468. doi: 10.1021/acsabm.1c00023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsabm.1c00023</ArticleId><ArticleId IdType="pubmed">35014430</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray G.G.R., Hossain A., Miller E.L., Bruchmann S., Balmer A.J., Matuszewska M., Herbert J., Hadjirin N.F., Mugabi R., Li G., et al. The emergence and diversification of a zoonotic pathogen from within the microbiota of intensively farmed pigs. Proc. Natl. Acad. Sci. USA. 2023;120:e2307773120. doi: 10.1073/pnas.2307773120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2307773120</ArticleId><ArticleId IdType="pmc">PMC10666105</ArticleId><ArticleId IdType="pubmed">37963246</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyette-Desjardins G., Auger J.P., Xu J., Segura M., Gottschalk M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes Infect. 2014;3:e45. doi: 10.1038/emi.2014.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.45</ArticleId><ArticleId IdType="pmc">PMC4078792</ArticleId><ArticleId IdType="pubmed">26038745</ArticleId></ArticleIdList></Reference><Reference><Citation>Segura M., Aragon V., Brockmeier S.L., Gebhart C., Greeff A., Kerdsin A., O’Dea M.A., Okura M., Salery M., Schultsz C., et al. Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis. Pathogens. 2020;9:374. doi: 10.3390/pathogens9050374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9050374</ArticleId><ArticleId IdType="pmc">PMC7281350</ArticleId><ArticleId IdType="pubmed">32422856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Wang J., Kang W., Zhang X., Kerdsin A., Yao H., Zheng H., Wu Z. Streptococcus suis serotype 4: A population with the potential pathogenicity in humans and pigs. Emerg. Microbes Infect. 2024;13:2352435. doi: 10.1080/22221751.2024.2352435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2024.2352435</ArticleId><ArticleId IdType="pmc">PMC11097711</ArticleId><ArticleId IdType="pubmed">38703011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatrongjit R., Fittipaldi N., Jenjaroenpun P., Wongsurawat T., Visetnan S., Zheng H., Gottschalk M., Kerdsin A. Genomic comparison of two Streptococcus suis serotype 1 strains recovered from porcine and human disease cases. Sci. Rep. 2023;13:5380. doi: 10.1038/s41598-023-32724-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32724-z</ArticleId><ArticleId IdType="pmc">PMC10068604</ArticleId><ArticleId IdType="pubmed">37009816</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang P., Wang M., Gottschalk M., Vela A.I., Estrada A.A., Wang J., Du P., Luo M., Zheng H., Wu Z. Genomic and pathogenic investigations of Streptococcus suis serotype 7 population derived from a human patient and pigs. Emerg. Microbes Infect. 2021;10:1960–1974. doi: 10.1080/22221751.2021.1988725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1988725</ArticleId><ArticleId IdType="pmc">PMC8525962</ArticleId><ArticleId IdType="pubmed">34635002</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrocchi-Rilo M., Martinez-Martinez S., Aguaron-Turrientes A., Roca-Martinez E., Garcia-Iglesias M.J., Perez-Fernandez E., Gonzalez-Fernandez A., Herencia-Lagunar E., Gutierrez-Martin C.B. Anatomical Site, Typing, Virulence Gene Profiling, Antimicrobial Susceptibility and Resistance Genes of Streptococcus suis Isolates Recovered from Pigs in Spain. Antibiotics. 2021;10:707. doi: 10.3390/antibiotics10060707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10060707</ArticleId><ArticleId IdType="pmc">PMC8230935</ArticleId><ArticleId IdType="pubmed">34208248</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan M.F., Tan J., Zeng Y.B., Li H.Q., Yang Q., Zhou R. Antimicrobial resistance phenotypes and genotypes of Streptococcus suis isolated from clinically healthy pigs from 2017 to 2019 in Jiangxi Province, China. J. Appl. Microbiol. 2021;130:797–806. doi: 10.1111/jam.14831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jam.14831</ArticleId><ArticleId IdType="pubmed">32881196</ArticleId></ArticleIdList></Reference><Reference><Citation>Matajira C.E.C., Moreno L.Z., Poor A.P., Gomes V.T.M., Dalmutt A.C., Parra B.M., Oliveira C.H., Barbosa M.R.F., Sato M.I.Z., Calderaro F.F., et al. Streptococcus suis in Brazil: Genotypic, Virulence, and Resistance Profiling of Strains Isolated from Pigs between 2001 and 2016. Pathogens. 2019;9:31. doi: 10.3390/pathogens9010031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9010031</ArticleId><ArticleId IdType="pmc">PMC7168627</ArticleId><ArticleId IdType="pubmed">31905664</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongkiettrakul S., Maneerat K., Arechanajan B., Malila Y., Srimanote P., Gottschalk M., Visessanguan W. Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs, asymptomatic pigs, and human patients in Thailand. BMC Vet. Res. 2019;15:5. doi: 10.1186/s12917-018-1732-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12917-018-1732-5</ArticleId><ArticleId IdType="pmc">PMC6318959</ArticleId><ArticleId IdType="pubmed">30606175</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaara M., Porro M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob. Agents Chemother. 1996;40:1801–1805. doi: 10.1128/AAC.40.8.1801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.40.8.1801</ArticleId><ArticleId IdType="pmc">PMC163420</ArticleId><ArticleId IdType="pubmed">8843284</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 1997;272:16010–16017. doi: 10.1074/jbc.272.25.16010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.25.16010</ArticleId><ArticleId IdType="pubmed">9188504</ArticleId></ArticleIdList></Reference><Reference><Citation>Abes R., Moulton H.M., Clair P., Yang S.T., Abes S., Melikov K., Prevot P., Youngblood D.S., Iversen P.L., Chernomordik L.V., et al. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: Structure-activity studies. Nucleic Acids Res. 2008;36:6343–6354. doi: 10.1093/nar/gkn541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn541</ArticleId><ArticleId IdType="pmc">PMC2582615</ArticleId><ArticleId IdType="pubmed">18796528</ArticleId></ArticleIdList></Reference><Reference><Citation>MacNair C.R., Rutherford S.T., Tan M.W. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat. Rev. Microbiol. 2024;22:262–275. doi: 10.1038/s41579-023-00993-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00993-0</ArticleId><ArticleId IdType="pubmed">38082064</ArticleId></ArticleIdList></Reference><Reference><Citation>Demidov V.V., Potaman V.N., Frank-Kamenetskii M.D., Egholm M., Buchard O., Sonnichsen S.H., Nielsen P.E. Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol. 1994;48:1310–1313. doi: 10.1016/0006-2952(94)90171-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-2952(94)90171-6</ArticleId><ArticleId IdType="pubmed">7945427</ArticleId></ArticleIdList></Reference><Reference><Citation>Good L., Awasthi S.K., Dryselius R., Larsson O., Nielsen P.E. Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 2001;19:360–364. doi: 10.1038/86753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/86753</ArticleId><ArticleId IdType="pubmed">11283595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nekhotiaeva N., Awasthi S.K., Nielsen P.E., Good L. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol. Ther. 2004;10:652–659. doi: 10.1016/j.ymthe.2004.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2004.07.006</ArticleId><ArticleId IdType="pubmed">15451449</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakoli M., Hashemi A., Vaezjalali M., Mohammadzadeh M., Goudarzi H. Inhibition of growth and gene expression in Staphylococcus aureus by anti-gyrA peptide nucleic acid. Future Microbiol. 2019;14:1123–1132. doi: 10.2217/fmb-2019-0103.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2019-0103</ArticleId><ArticleId IdType="pubmed">31512520</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., He Y., Xia Y., Wang L., Liang S. Inhibition of gene expression and growth of multidrug-resistant Acinetobacter baumannii by antisense peptide nucleic acids. Mol. Biol. Rep. 2014;41:7535–7541. doi: 10.1007/s11033-014-3643-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-014-3643-2</ArticleId><ArticleId IdType="pubmed">25091942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000;56:318–325. doi: 10.1034/j.1399-3011.2000.00723.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3011.2000.00723.x</ArticleId><ArticleId IdType="pubmed">11095185</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard J.J., Sturge C.R., Moustafa D.A., Daly S.M., Marshall-Batty K.R., Felder C.F., Zamora D., Yabe-Gill M., Labandeira-Rey M., Bailey S.M., et al. Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers. Antimicrob. Agents Chemother. 2017;61:e01938-16. doi: 10.1128/AAC.01938-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.01938-16</ArticleId><ArticleId IdType="pmc">PMC5365667</ArticleId><ArticleId IdType="pubmed">28137807</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly S.M., Sturge C.R., Felder-Scott C.F., Geller B.L., Greenberg D.E. MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli. mBio. 2017;8:e01315-17. doi: 10.1128/mBio.01315-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01315-17</ArticleId><ArticleId IdType="pmc">PMC5676038</ArticleId><ArticleId IdType="pubmed">29114023</ArticleId></ArticleIdList></Reference><Reference><Citation>Aunins T.R., Erickson K.E., Chatterjee A. Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Proc. Natl. Acad. Sci. USA. 2020;117:30699–30709. doi: 10.1073/pnas.1922187117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1922187117</ArticleId><ArticleId IdType="pmc">PMC7720196</ArticleId><ArticleId IdType="pubmed">33199638</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh E., Zhang Q., Jeon B. Target optimization for peptide nucleic acid (PNA)-mediated antisense inhibition of the CmeABC multidrug efflux pump in Campylobacter jejuni. J. Antimicrob. Chemother. 2014;69:375–380. doi: 10.1093/jac/dkt381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkt381</ArticleId><ArticleId IdType="pmc">PMC3886934</ArticleId><ArticleId IdType="pubmed">24084637</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh S., Loeffler A., Lloyd D.H., Nair S.P., Good L. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro. BMC Microbiol. 2015;15:262. doi: 10.1186/s12866-015-0599-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-015-0599-x</ArticleId><ArticleId IdType="pmc">PMC4642645</ArticleId><ArticleId IdType="pubmed">26560174</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleitas Martinez O., Cardoso M.H., Ribeiro S.M., Franco O.L. Recent Advances in Anti-virulence Therapeutic Strategies with a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition. Front. Cell Infect. Microbiol. 2019;9:74. doi: 10.3389/fcimb.2019.00074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00074</ArticleId><ArticleId IdType="pmc">PMC6454102</ArticleId><ArticleId IdType="pubmed">31001485</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasko D.A., Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 2010;9:117–128. doi: 10.1038/nrd3013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3013</ArticleId><ArticleId IdType="pubmed">20081869</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhlen S., Dersch P. Anti-virulence Strategies to Target Bacterial Infections. Curr. Top. Microbiol. Immunol. 2016;398:147–183. doi: 10.1007/82_2015_490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/82_2015_490</ArticleId><ArticleId IdType="pubmed">26942418</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly S.M., Elmore B.O., Kavanaugh J.S., Triplett K.D., Figueroa M., Raja H.A., El-Elimat T., Crosby H.A., Femling J.K., Cech N.B., et al. omega-Hydroxyemodin limits Staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Antimicrob. Agents Chemother. 2015;59:2223–2235. doi: 10.1128/AAC.04564-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.04564-14</ArticleId><ArticleId IdType="pmc">PMC4356798</ArticleId><ArticleId IdType="pubmed">25645827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sully E.K., Malachowa N., Elmore B.O., Alexander S.M., Femling J.K., Gray B.M., DeLeo F.R., Otto M., Cheung A.L., Edwards B.S., et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathog. 2014;10:e1004174. doi: 10.1371/journal.ppat.1004174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004174</ArticleId><ArticleId IdType="pmc">PMC4055767</ArticleId><ArticleId IdType="pubmed">24945495</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.M., Odahara M., Yoshizumi T., Oikawa K., Kimura M., Su’etsugu M., Numata K. Cell-Penetrating Peptide-Mediated Transformation of Large Plasmid DNA into Escherichia coli. ACS Synth. Biol. 2019;8:1215–1218. doi: 10.1021/acssynbio.9b00055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssynbio.9b00055</ArticleId><ArticleId IdType="pubmed">31008591</ArticleId></ArticleIdList></Reference><Reference><Citation>Numata K., Kaplan D.L. Silk-based gene carriers with cell membrane destabilizing peptides. Biomacromolecules. 2010;11:3189–3195. doi: 10.1021/bm101055m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bm101055m</ArticleId><ArticleId IdType="pmc">PMC3037451</ArticleId><ArticleId IdType="pubmed">20942485</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y., Dong W., Ma J., Zhang Y., Pan Z., Yao H. Utilization of the ComRS system for the rapid markerless deletion of chromosomal genes in Streptococcus suis. Future Microbiol. 2019;14:207–222. doi: 10.2217/fmb-2018-0279.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2018-0279</ArticleId><ArticleId IdType="pubmed">30663887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaccaria E., van Baarlen P., de Greeff A., Morrison D.A., Smith H., Wells J.M. Control of competence for DNA transformation in streptococcus suis by genetically transferable pherotypes. PLoS ONE. 2014;9:e99394. doi: 10.1371/journal.pone.0099394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099394</ArticleId><ArticleId IdType="pmc">PMC4072589</ArticleId><ArticleId IdType="pubmed">24968201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Wang W., Tang M., Shao J., Dai C., Zhang W., Fan H., Yao H., Zong J., Chen D., et al. Comparative genomic analysis shows that Streptococcus suis meningitis isolate SC070731 contains a unique 105K genomic island. Gene. 2014;535:156–164. doi: 10.1016/j.gene.2013.11.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2013.11.044</ArticleId><ArticleId IdType="pubmed">24316490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Zhang W., Lu C. Comparative proteome analysis of secreted proteins of Streptococcus suis serotype 9 isolates from diseased and healthy pigs. Microb. Pathog. 2008;45:159–166. doi: 10.1016/j.micpath.2008.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2008.04.009</ArticleId><ArticleId IdType="pubmed">18554861</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldred K.J., Kerns R.J., Osheroff N. Mechanism of quinolone action and resistance. Biochemistry. 2014;53:1565–1574. doi: 10.1021/bi5000564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi5000564</ArticleId><ArticleId IdType="pmc">PMC3985860</ArticleId><ArticleId IdType="pubmed">24576155</ArticleId></ArticleIdList></Reference><Reference><Citation>Goltermann L., Nielsen P.E. PNA Antisense Targeting in Bacteria: Determination of Antibacterial Activity (MIC) of PNA-Peptide Conjugates. Methods Mol. Biol. 2020;2105:231–239. doi: 10.1007/978-1-0716-0243-0_14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-0243-0_14</ArticleId><ArticleId IdType="pubmed">32088874</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>